Manuscript citation: Inman B, Butler J, George-Nichol S, Kovalenko G, Savidge T, Vergnetti Y, Pongratz C, Bee E, DiNardo AR, Kay A, Mandalakas A, Bortz E, Ness TE Application of FreezeTB, a targeted nanopore sequencing assay, for identification of drug resistance and lineages among pulmonary tuberculosis cases in Alaska. Microbiology Spectrum 14(1). doi: 10.1128/spectrum.02335-25 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingProtocol in use; further development will be included from user feedback
Created: October 31, 2025
Last Modified: October 31, 2025
Protocol Integer ID: 231206
Keywords: lineage of mycobacterium tuberculosis, oxford nanopore technologies minion platform, pcr amplicon analysis of drug resistance mutation, mycobacterium tuberculosis, targeted next generation sequencing, next generation sequencing, freeze tb, drug resistance mutation, tuberculosis, mycobacterium, nanopore, bioinformatic software, low dependency bioinformatic software, pcr amplicon analysis, tb, drug resistance, primer ftb v11, mutation